Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review

被引：5

作者：

Gatto, Lidia ^{[1
]}

Franceschi, Enrico ^{[1
]}

Tosoni, Alicia ^{[1
]}

Di Nunno, Vincenzo ^{[1
]}

Maggio, Ilaria ^{[1
]}

Tonon, Caterina ^{[2
]}

Lodi, Raffaele ^{[2
]}

Agati, Raffaele ^{[2
]}

Bartolini, Stefania ^{[1
]}

Brandes, Alba Ariela ^{[1
]}

机构：

[1] Azienda USL Bologna, Dept Med Oncol, Bologna, Italy

[2] IRCCS Ist Sci Neurol Bologna, Bologna, Italy

来源：

CLINICAL CASE REPORTS | 2021年 / 9卷 / 08期

关键词：

antiangiogenic treatment; glioblastoma multiforme; pseudoresponse; RANO criteria; regorafenib; tyrosine kinase inhibitors; RESPONSE ASSESSMENT; BEVACIZUMAB; TEMOZOLOMIDE; PROGRESSION; CRITERIA; THERAPY; GLIOMAS; TRIAL;

D O I：

10.1002/ccr3.4604

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1-weighted images and a simultaneous hyperintensity on T2-weighted or fluid-attenuated inversion recovery images.

引用

页数：6

共 30 条

[1] A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma [J].

Addeo, Raffaele ;

Caraglia, Michele ;

De Santi, M. Serena ;

Montella, Liliana ;

Abbruzzese, Alberto ;

Parlato, Ciro ;

Vincenzi, Bruno ;

Carraturo, Marco ;

Faiola, Vincenzo ;

Genovese, Michele ;

Cennamo, Gregorio ;

Del Prete, Salvatore .

JOURNAL OF NEURO-ONCOLOGY, 2011, 102 (03) :417-424

[2] Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas [J].

Albert, Nathalie L. ;

Weller, Michael ;

Suchorska, Bogdana ;

Galldiks, Norbert ;

Soffietti, Riccardo ;

Kim, Michelle M. ;

La Fougere, Christian ;

Pope, Whitney ;

Law, Ian ;

Arbizu, Javier ;

Chamberlain, Marc C. ;

Vogelbaum, Michael ;

Ellingson, Ben M. ;

Tonn, Joerg C. .

NEURO-ONCOLOGY, 2016, 18 (09) :1199-1208

[3] Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse [J].

Arevalo, Octavio D. ;

Soto, Carolina ;

Rabiei, Pejman ;

Kamali, Arash ;

Ballester, Leomar Y. ;

Esquenazi, Yoshua ;

Zhu, Jay-Jiguang ;

Riascos, Roy Francisco .

FRONTIERS IN NEUROLOGY, 2019, 10

[4] Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study [J].

Brandes, Alba A. ;

Finocchiaro, Gaetano ;

Zagonel, Vittorina ;

Reni, Michele ;

Fabi, Alessandra ;

Caserta, Claudia ;

Tosoni, Alicia ;

Eoli, Marica ;

Lombardi, Giuseppe ;

Clavarezza, Matteo ;

Paccapelo, Alexandro ;

Bartolini, Stefania ;

Cirillo, Luigi ;

Agati, Raffaele ;

Franceschi, Enrico .

ONCOTARGET, 2017, 8 (33) :55575-55581

[5] AVAREG: a phase 2, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma [J].

Brandes, Alba A. ;

Finocchiaro, Gaetano ;

Zagonel, Vittorina ;

Reni, Michele ;

Caserta, Claudia ;

Fabi, Alessandra ;

Clavarezza, Matteo ;

Maiello, Evaristo ;

Eoli, Marica ;

Lombardi, Giuseppe ;

Monteforte, Marta ;

Proietti, Emanuela ;

Agati, Raffaele ;

Eusebi, Vincenzo ;

Franceschi, Enrico .

NEURO-ONCOLOGY, 2016, 18 (09) :1304-1312

[6] Nitrosoureas in the Management of Malignant Gliomas [J].

Brandes, Alba A. ;

Bartolotti, Marco ;

Tosoni, Alicia ;

Franceschi, Enrico .

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (02) :1-7

[7] Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) [J].

Brandes, Alba A. ;

Tosoni, A. ;

Franceschi, E. ;

Blatt, V. ;

Santoro, A. ;

Faedi, M. ;

Amista, P. ;

Gardiman, M. ;

Labianca, R. ;

Bianchini, C. ;

Ermani, M. ;

Reni, M. .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) :769-775

[8] Pseudoprogression and pseudoresponse in the treatment of gliomas [J].

Brandsma, Dieta ;

van den Bent, Martin J. .

CURRENT OPINION IN NEUROLOGY, 2009, 22 (06) :633-638

[9] Treatment of recurrent glioblastoma: state-of-the-art and future perspectives [J].

Di Nunno, Vincenzo ;

Franceschi, Enrico ;

Tosoni, Alicia ;

Di Battista, Monica ;

Gatto, Lidia ;

Lamperini, Cinzia ;

Minichillo, Santino ;

Mura, Antonella ;

Bartolini, Stefania ;

Brandes, Alba A. .

EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (09) :785-795

[10] Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment? [J].

Donnem, Tom ;

Hu, Jiangting ;

Ferguson, Mary ;

Adighibe, Omanma ;

Snell, Cameron ;

Harris, Adrian L. ;

Gatter, Kevin C. ;

Pezzella, Francesco .

CANCER MEDICINE, 2013, 2 (04) :427-436

← 1 2 3 →